ProQR Therapeutics (PRQR) Treasury Shares (2016 - 2026)
ProQR Therapeutics (PRQR) posted Treasury Shares of $2.7 million for Q1 2026, up 0.51% sequentially from $2.7 million in Q4 2025, and up 10.38% YoY from $2.5 million in Q1 2025.
ProQR Therapeutics (PRQR) Treasury Shares (2016 - 2026) Analysis & Trends
ProQR Therapeutics has reported Treasury Shares for 11 years, with the latest figure at $2.7 million in Q1 2026.
- Quarterly Treasury Shares rose 10.38% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 10.38% YoY) and the FY2025 annual result came in at $2.7 million, up 2.46% from the prior year.
- Treasury Shares improved to $2.7 million in Q1 2026 per PRQR's latest filing, from $2.7 million in the prior quarter.
- Over five years, Treasury Shares peaked at $4.0 million in Q1 2022 and troughed at $2.5 million in Q1 2025.
- A 5-year average of $3.1 million and a median of $2.8 million in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2024 and 2026: Treasury Shares fell 23.24% in 2024, then advanced 10.38% in 2026.
- Over 5 years, Treasury Shares stood at $3.5 million in 2022, then fell by 11.02% to $3.1 million in 2023, then declined by 14.25% to $2.7 million in 2024, then increased by 2.46% to $2.7 million in 2025, then climbed by 0.51% to $2.7 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $2.7 million, $2.7 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | 2.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.75 Mn |
| Mar 31, 2026 | 2.75 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 2.76 Mn |
| Mar 31, 2024 | 2.81 Mn |
| Mar 31, 2024 | 2.81 Mn |
| Dec 31, 2023 | 3.11 Mn |
| Dec 31, 2023 | 3.11 Mn |